Enter a word or phrase in any language 👆
Language:
Translation and analysis of words by ChatGPT artificial intelligence
On this page you can get a detailed analysis of a word or phrase, produced by the best artificial intelligence technology to date:
- how the word is used
- frequency of use
- it is used more often in oral or written speech
- word translation options
- usage examples (several phrases with translation)
- etymology
What (who) is McArdle disease - definition
HUMAN DISEASE
McArdle's Disease; McArdle disease; GSD type V; McArdle's disease; Mac Ardle disease; Glycogen storage disease type v; Phosphorylase Deficiency; McArdles syndrome; McArdle syndrome; Glycogenosis type V; Myophosphorylase deficiency; Mcardles disease
Glycogen storage disease type V
Glycogen storage disease type V (GSD5, GSD-V), also known as McArdle's disease, is a metabolic disorder, more specifically a muscle glycogen storage disease, caused by a deficiency of myophosphorylase. Its incidence is reported as one in 100,000,http://mcardlesdisease.
McArdle
FAMILY NAME
Mcardle
The surname McArdle or MacArdle was the twelfth most numerous in its homeland of County Monaghan in 1970. The surname in Irish is MacArdghail, from ardghal, meaning 'high valour' or from the Irish "ardghail" meaning "tall foreigner" with roots "ard" meaning "tall" and "gail" meaning "foreigner", indicative of their original ancestor being a Viking or from Viking stock.
Tom McArdle
AMERICAN FILM EDITOR
McArdle, Tom
Tom McArdle is an American film editor. He is best known as the editor for every film written and directed by Tom McCarthy, including The Station Agent (2003), The Visitor (2007), Win Win (2011) and The Cobbler (2014).
Wikipedia
Glycogen storage disease type V
Glycogen storage disease type V (GSD5, GSD-V), also known as McArdle's disease, is a metabolic disorder, one of the metabolic myopathies, more specifically a muscle glycogen storage disease, caused by a deficiency of myophosphorylase. Its incidence is reported as one in 100,000,roughly the same as glycogen storage disease type I.
The disease was first reported in 1951 by Dr. Brian McArdle of Guy's Hospital, London.
